
Capitis Pharmaceuticals Private Limited
About Capitis Pharmaceuticals Private Limited
Data last updated:
Capitis Pharmaceuticals Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 March 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24305MH2013PTC241064. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Atul Vijaykumar Ganjewar and Prashant Vijaykumar Ganjewar.
Its last annual general meeting (AGM) was held on 30 June 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Lig A/19/8 Cidco Waluj Mahanagar K. Wadgaon, Aurangabad, Maharashtra, India – 431112.
As per the financials filed for FY 2022, the company reported a revenue of ₹2.1 Lakh, a decline of 39% compared to the previous year. For the same year it recorded a net loss of ₹1.07 Lakh (net margin -50.8%) and EBITDA of -₹99,506 (EBITDA margin -47.4%). Revenue has declined at a compounded annual rate (CAGR) of 54% over three years and 40% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Capitis Pharmaceuticals Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressLig A/19/8 Cidco Waluj Mahanagar K. Wadgaon, Aurangabad, Maharashtra, India – 431112
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Capitis Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Capitis Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Capitis Pharmaceuticals Private Limited, buy the company report.
Financials of Capitis Pharmaceuticals Private Limited
FY 2022 filings availableCapitis Pharmaceuticals Private Limited reported revenue of ₹2.1 Lakh (down 39% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 40% over five years, including a 39% fall in the latest year. EBITDA rose 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹99,506 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.07 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -47.4% | ||||
| Net Profit Margin | -50.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Capitis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Capitis Pharmaceuticals Private Limited
Capitis Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atul Vijaykumar Ganjewar | Director | 16 Mar 2013 | 13 Years 8 Months | Current |
| Prashant Vijaykumar Ganjewar | Director | 16 Mar 2013 | 13 Years 8 Months | Current |
Peer comparison
Capitis Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medigenium Pharmaceuticals Private Limited | ₹2.11 Lakh (FY 2025) | -88.0% | Patna, Bihar, India | |||
| Sneha Natura Private Limited | ₹2.11 Lakh (FY 2017) | 12.0% | Bangalore, Karnataka, India | |||
| Capitis Pharmaceuticals Private Limitedthis company | ₹2.1 Lakh (FY 2022) | -₹1.07 Lakh | -50.8% | -39.0% | Aurangabad, Maharashtra, India | |
| Picks Pharmaceuticals Private Limited | ₹2.1 Lakh (FY 2020) | -33.0% | Navi Mumbai, Maharashtra, India | |||
| Yathaavat Pharma Private Limited | ₹2.1 Lakh (FY 2024) | 374.0% | Agra, Uttar Pradesh, India | |||
| Foryou Pharmaceuticals Private Limited | ₹2.1 Lakh (FY 2022) | -67.0% | Meerut, Uttar Pradesh, India | |||
| Biosense Pharmaceuticals Private Limited | ₹2.08 Lakh (FY 2024) | Patna, Bihar, India |
To see the full peer comparison of Capitis Pharmaceuticals Private Limited, buy the company report.
Auditor
Capitis Pharmaceuticals Private Limited is audited by CHAUDHARY MALPANI BHANDARI & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHAUDHARY MALPANI BHANDARI & CO | FY 2019 | 124463W |
Shareholding
The shareholding of Capitis Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Capitis Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Capitis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Capitis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Capitis Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Capitis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Capitis Pharmaceuticals Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Vishnu Dashrath Gajbar ceased to be Director on 09 Aug 2019.
Frequently asked questions
Capitis Pharmaceuticals is an active private limited company based in Aurangabad, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 March 2013 (13+ years old) and is registered under CIN U24305MH2013PTC241064.
Capitis Pharmaceuticals has 2 current directors:
- Atul Vijaykumar Ganjewar - Director
- Prashant Vijaykumar Ganjewar - Director
The latest financial statements of Capitis Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 June 2022. Year-wise statements from 2015 are in the company report.
No. Capitis Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Capitis Pharmaceuticals is U24305MH2013PTC241064. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Capitis Pharmaceuticals was incorporated on 16 March 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Capitis Pharmaceuticals by revenue are Medigenium Pharmaceuticals Private Limited, Sneha Natura Private Limited, Picks Pharmaceuticals Private Limited, Yathaavat Pharma Private Limited, Foryou Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Vishnu Dashrath Gajbar ceased to be Director on 09 Aug 2019. Atul Vijaykumar Ganjewar was appointed as Director on 16 Mar 2013. Prashant Vijaykumar Ganjewar was appointed as Director on 16 Mar 2013.
The registered office of Capitis Pharmaceuticals is at Lig A198 Cidco Waluj Mahanagar K. Wadgaon, Aurangabad, Maharashtra, India – 431112.
Capitis Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Capitis Pharmaceuticals is compliant as of 27 August 2026. The company is actively filing with the Registrar of Companies.

